IBDEI061 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2577,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,2577,1,5,0)
 ;;=5^LATE EFF CEREB/VASC-HEMIPLESIA
 ;;^UTILITY(U,$J,358.3,2577,2)
 ;;=^317910
 ;;^UTILITY(U,$J,358.3,2578,0)
 ;;=438.30^^21^204^5
 ;;^UTILITY(U,$J,358.3,2578,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2578,1,4,0)
 ;;=4^438.30
 ;;^UTILITY(U,$J,358.3,2578,1,5,0)
 ;;=5^LATE EFF CEREB/VASC-MON U/L UN
 ;;^UTILITY(U,$J,358.3,2578,2)
 ;;=^317913
 ;;^UTILITY(U,$J,358.3,2579,0)
 ;;=438.82^^21^204^3
 ;;^UTILITY(U,$J,358.3,2579,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2579,1,4,0)
 ;;=4^438.82
 ;;^UTILITY(U,$J,358.3,2579,1,5,0)
 ;;=5^LATE EFF CEREB/VASC-DYSPHAGIA
 ;;^UTILITY(U,$J,358.3,2579,2)
 ;;=^317923
 ;;^UTILITY(U,$J,358.3,2580,0)
 ;;=V41.0^^22^205^19
 ;;^UTILITY(U,$J,358.3,2580,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2580,1,1,0)
 ;;=1^V41.0
 ;;^UTILITY(U,$J,358.3,2580,1,2,0)
 ;;=2^VISUALLY IMPAIRED
 ;;^UTILITY(U,$J,358.3,2580,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,2581,0)
 ;;=250.01^^22^205^14
 ;;^UTILITY(U,$J,358.3,2581,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2581,1,1,0)
 ;;=1^250.01
 ;;^UTILITY(U,$J,358.3,2581,1,2,0)
 ;;=2^IDDM
 ;;^UTILITY(U,$J,358.3,2581,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,2582,0)
 ;;=250.00^^22^205^16
 ;;^UTILITY(U,$J,358.3,2582,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2582,1,1,0)
 ;;=1^250.00
 ;;^UTILITY(U,$J,358.3,2582,1,2,0)
 ;;=2^NIDDM
 ;;^UTILITY(U,$J,358.3,2582,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,2583,0)
 ;;=401.0^^22^205^11
 ;;^UTILITY(U,$J,358.3,2583,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2583,1,1,0)
 ;;=1^401.0
 ;;^UTILITY(U,$J,358.3,2583,1,2,0)
 ;;=2^HYPERTENSION MALIGNANT
 ;;^UTILITY(U,$J,358.3,2583,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,2584,0)
 ;;=796.0^^22^205^2
 ;;^UTILITY(U,$J,358.3,2584,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2584,1,1,0)
 ;;=1^796.0
 ;;^UTILITY(U,$J,358.3,2584,1,2,0)
 ;;=2^ABNORMAL LAB FINDINGS
 ;;^UTILITY(U,$J,358.3,2584,2)
 ;;=^273463
 ;;^UTILITY(U,$J,358.3,2585,0)
 ;;=305.1^^22^205^17
 ;;^UTILITY(U,$J,358.3,2585,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2585,1,1,0)
 ;;=1^305.1
 ;;^UTILITY(U,$J,358.3,2585,1,2,0)
 ;;=2^SMOKER
 ;;^UTILITY(U,$J,358.3,2585,2)
 ;;=^119899
 ;;^UTILITY(U,$J,358.3,2586,0)
 ;;=272.2^^22^205^15
 ;;^UTILITY(U,$J,358.3,2586,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2586,1,1,0)
 ;;=1^272.2
 ;;^UTILITY(U,$J,358.3,2586,1,2,0)
 ;;=2^MIXED HYPERLIPIDEMIA
 ;;^UTILITY(U,$J,358.3,2586,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,2587,0)
 ;;=401.9^^22^205^12
 ;;^UTILITY(U,$J,358.3,2587,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2587,1,1,0)
 ;;=1^401.9
 ;;^UTILITY(U,$J,358.3,2587,1,2,0)
 ;;=2^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,2587,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,2588,0)
 ;;=286.59^^22^205^9
 ;;^UTILITY(U,$J,358.3,2588,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2588,1,1,0)
 ;;=1^286.59
 ;;^UTILITY(U,$J,358.3,2588,1,2,0)
 ;;=2^HEM DISORDER D/T CIRC ANTICOAG
 ;;^UTILITY(U,$J,358.3,2588,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,2589,0)
 ;;=401.1^^22^205^13
 ;;^UTILITY(U,$J,358.3,2589,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2589,1,1,0)
 ;;=1^401.1
 ;;^UTILITY(U,$J,358.3,2589,1,2,0)
 ;;=2^HYPERTENSION,BENIGN
 ;;^UTILITY(U,$J,358.3,2589,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,2590,0)
 ;;=796.4^^22^205^1
 ;;^UTILITY(U,$J,358.3,2590,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2590,1,1,0)
 ;;=1^796.4
 ;;^UTILITY(U,$J,358.3,2590,1,2,0)
 ;;=2^ABNORMAL CLINICAL FINDINGS
 ;;^UTILITY(U,$J,358.3,2590,2)
 ;;=^273466
 ;;^UTILITY(U,$J,358.3,2591,0)
 ;;=250.80^^22^205^8
 ;;^UTILITY(U,$J,358.3,2591,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2591,1,1,0)
 ;;=1^250.80
